Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Atrial fibrillation (AF) is the most common cardiac arrhythmia in clinical practice affecting up to 1% of the general population. There is a higher prevalence and incidence with increasing age and burden of chronic heart disease . Treatment for AF represents a significant healthcare cost, estimated to be about Euro 13.5 billion annually in the European Union. Manage-ment of AF remains challenging especially with new pharmacological and non-pharmacological approaches becoming readily available. This review article discusses the multitude of therapeutic options and how they may be applied to best effect.

Type

Journal article

Journal

Minerva Cardioangiol

Publication Date

12/2008

Volume

56

Pages

605 - 621

Keywords

Algorithms, Atrial Fibrillation, Decision Trees, Humans, Thromboembolism